iifl-logo

Parenteral Drugs India Ltd Key Ratios

2.9
(1.75%)
Aug 21, 2023|01:45:11 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-61.82

-85.16

-6.51

-11.72

Op profit growth

-19.83

-30.25

8.42

-45.67

EBIT growth

-8.63

-27.28

5.28

-26.5

Net profit growth

6.69

-4.09

0.94

1.09

Profitability ratios (%)

OPM

-96.75

-46.07

-9.8

-8.45

EBIT margin

-238.63

-99.7

-20.34

-18.06

Net profit margin

-1,000.31

-357.87

-55.37

-51.28

RoCE

-213.26

-9.01

-6.3

-4.64

RoNW

5.57

11.5

207.5

-19.13

RoA

-223.57

-8.08

-4.29

-3.29

Per share ratios (₹)

EPS

-40.82

-38.26

0

0

Dividend per share

0

0

0

0

Cash EPS

-46.63

-44.07

-48.02

-47.86

Book value per share

-203.29

-162.52

-3.76

-5.84

Valuation ratios

P/E

-0.07

-0.06

0

0

P/CEPS

-0.06

-0.05

-0.33

-0.57

P/B

-0.01

-0.01

-0.34

-4.66

EV/EBIDTA

-48.53

-39.22

-35.24

-51.12

Payout (%)

Dividend payout

0

0

0

0

Tax payout

-21.2

-19.51

-15.79

-7.5

Liquidity ratios

Debtor days

0

20.95

56.06

122.92

Inventory days

42.74

161.86

61.22

80.48

Creditor days

-119.98

-231.76

-72.56

-59.68

Leverage ratios

Interest coverage

0.23

0.28

0.44

0.48

Net debt / equity

-0.92

-1.15

-56.89

-44.07

Net debt / op. profit

-47.46

-38.04

-30.31

-39.57

Cost breakup (₹)

Material costs

-46.54

-19.83

-72.82

-67.01

Employee costs

-119.26

-60.25

-10.21

-9.06

Other costs

-30.94

-65.98

-26.76

-32.38

Parenteral Drugs : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.